Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Cash from Operations (2023 - 2025)

Cannabis Bioscience International Holdings' Cash from Operations history spans 3 years, with the latest figure at 5493.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 92.38% year-over-year to 5493.0; the TTM value through Nov 2025 reached 336329.0, down 17.59%, while the annual FY2025 figure was 329627.0, 31.24% up from the prior year.
  • Cash from Operations for Q4 2025 was 5493.0 at Cannabis Bioscience International Holdings, up from 103712.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 5493.0 in Q4 2025 and bottomed at 221247.0 in Q4 2023.
  • The 3-year median for Cash from Operations is 93262.0 (2025), against an average of 108937.0.
  • The largest annual shift saw Cash from Operations surged 95.49% in 2024 before it crashed 812.43% in 2025.
  • A 3-year view of Cash from Operations shows it stood at 221247.0 in 2023, then skyrocketed by 67.42% to 72090.0 in 2024, then soared by 92.38% to 5493.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Cash from Operations are 5493.0 (Q4 2025), 103712.0 (Q3 2025), and 144312.0 (Q2 2025).